Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
about
Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells.Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer.In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporterLMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1
P2860
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Co-treatment with arsenic trio ...... l of nasopharyngeal carcinoma.
@en
type
label
Co-treatment with arsenic trio ...... l of nasopharyngeal carcinoma.
@en
prefLabel
Co-treatment with arsenic trio ...... l of nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Co-treatment with arsenic trio ...... l of nasopharyngeal carcinoma.
@en
P2093
Fayong Luo
Joseph A Lasky
Mark D Sides
Meredith L Sosulski
P2860
P2888
P356
10.1186/1743-422X-10-152
P577
2013-05-16T00:00:00Z
P6179
1018447965